Biopôle SA continues its expansion with the construction of three new buildings. By 2024, an additional 23’000 square meters of office and laboratory space will be available to accommodate companies…
Biel-based medtech company Optimo Medical has sealed a partnership with Ansys, a global 1.516 billion revenue company providing multiphysics engineering simulation software since 1970. This partnership will help Optimo…
With the support of the Touring Club Switzerland, an endowed professorship in emergency telemedicine was appointed at the University of Bern, aiming to create the ideal framework to achieve major…
ZETA, an Austrian engineering specialist for the pharmaceutical and biotech industries, has recently opened a subsidiary in Visp, with the aim of working even more closely with the global players…
Using a special gas treatment, the Fribourg-based company Medistri suppresses all germs contained in the vials destined to receive the Covid-19 vaccine. The company expects to sterilize more than 220…
With the foundation of the Multidisciplinary Center for Infectious Diseases and Immunity, the University of Bern will be able to study the societal, economic and healthcare impact of infectious diseases.…
With the support of the Touring Club Switzerland, an endowed professorship in emergency telemedicine was appointed at the University of Bern, aiming to create the ideal framework to achieve major…
Researchers from EPFL have invented a technique to navigate electronic devices that are smaller than human hair inside blood vessels and reach arterioles. The next step will be conducting in…
With the launch of its CE-Mark certified device cSOFA, which assesses the severity of Covid-19 among patients within only five minutes of analyzing a blood sample, Abionic aims to prevent…
Leading global biotech company CSL Behring has recently inaugurated a new state-of-the-art immunoglobulin manufacturing plant in the Swiss canton of Bern. In 2017, CSL Behring decided to expand its manufacturing capacities in…
With the foundation of the Multidisciplinary Center for Infectious Diseases and Immunity, the University of Bern will be able to study the societal, economic and healthcare impact of infectious diseases.…
Valued at CHF 86 million and scheduled to be operational in 2024, the Pôle Santé campus aims to be a platform for the exchange of knowledge, experience and opportunities in…
See our Cookie Privacy Policy Here